Form D · Other Technology
PROGNOZ LAB INC
Washington, DC · CIK 0001538436
Offering snapshot reported Jan 17, 2012 · SEC filing
- Reported sold
- $900 Offering amount: $900
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 30, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 17, 2012 | Initial | $900 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-171934
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NONE | None |
Source: Form D, filed Jan 17, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dmitriy Andrianov | Director, Executive, Promoter |
| Misha Belkindas | Promoter |
| Vladimir Eskin | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1899 Pennsylvania Ave Nw Ste 320
Washington, DC, 20006
Washington, DC, 20006